Our expert teams can help with process and analytical development at any stage.

We have extensive expertise in designing processes, developing systems that are streamlined and more efficient, and optimising existing processes to increase yield and decrease timescales.

We work with a range of different vaccine platforms. So you can test out processes on new platforms, expression systems, bioreactors, fermenters and purification steps, and scale up when appropriate.

Alongside process development, our specialist analytical development teams will develop systems to ensure that your vaccine has the correct identity, purity, potency and quantity.

Our analytical development capabilities include:

  • Peptide mapping and Intact mass
  • ELISA/ELISpot assays
  • UPLC including SEC-MALS
  • Protein profile (SDS-PAGE, WB, IEF)
  • Karl Fischer water determination
  • Dynamic Light Scattering
  • Handling biologicals to safety level 2 and performing bioassays

Meet the expert

Martin Smith, PhD

VMIC Head of Manufacturing Science and Technology, and Process and Analytical Development

Martin brings to VMIC vast experience in technical, managerial and leadership roles across early and late phase bioprocess development and validation projects in Biopharma R&D & GMP operations. He has experience in cell and gene therapy facility design, laboratory start-up, and process development and manufacturing.

Further Reading

Drug product

Whether your vaccine has been formulated at VMIC or elsewhere, you can use our GMP fill–finish suites to make the final product.

Drug substance

If you need a small batch of vaccine for a Phase 1 trial, millions of doses, or any scale in between, our GMP drug substance suites and advanced equipment are available to produce your vaccine.

Support and Training

We provide support, guidance and knowledge to the vaccine field.